The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Session Two of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada this Weekend

September 7th is World Duchenne Awareness Day. Over the past decades, life expectancy of individuals affected by Duchenne muscular dystrophy (DMD) has increased significantly, and adults with DMD are not an exception anymore. Adult life with DMD comes with new challenges and opportunities as well as with new medical issues. This World Duchenne Awareness Day, organizations are globally advocating to create opportunities for young adults and adults with DMD to live their lives to the fullest. Read more about today’s global event here

The NMD4C is proud to partner with Jesse’s Journey and Muscular Dystrophy Canada (MDC) in hosting the first national summit solely focused on DMD for health care providers across Canada, with the theme for this year’s event being ‘Addressing DMD Standards of Care in Canada.’

There’s still time to register for the  second session of the CPD-accredited Defeat Duchenne Canadian Conference, coming up this weekend!

Register for session two here

 

The objectives of this session are to:

  1. Describe the current standard of Duchenne neuromuscular management and transition from pediatric to adult care in Canada
  2. Identify and address current gaps in neuromuscular management and transition from pediatric to adult care within their clinics
  3. Describe the lived experience of neuromuscular management and transition from pediatric to adult clinical care for Duchenne patients and their families

 

The second session will take place on:

Friday, September 10 from 11 a.m. to 2 p.m. EDT: Neuromuscular Management

Moderated by: Dr. Kathryn Selby (Pediatric Neurologist) and Dr. Hanns Lochmüller (Adult Neurologist)

Agenda: 

  • DMD care considerations – Dr. Kathryn Selby (Pediatric Neurologist)
  • Newborn screening – Dr. Jim Dowling (Pediatric Neurologist)
  • Access to medications – Dr. Craig Campbell (Pediatric Neurologist)
  • Pediatric/Adult DMD clinics – Dr. Kerri Schellenberg (Adult Neurologist) and Dr. Mike Berger (Adult Physiatrist)
  • Education in DMD – Dr. Hanns Lochmüller (Adult Neurologist)
  • Steroid management – Dr. Hugh McMillan (Pediatric Neurologist)
  • Vamorolone – Dr. Eric Hoffman (Researcher, CEO of ReveraGen)
  • Exon skipping – Dr. Craig Campbell (Pediatric Neurologist)
  • How to discuss research with families – Dr. Jim Dowling
  • Importance of Nutrition – Alex Printis (Dietitian)
  • Future directions – Dr. Kathryn Selby (Pediatric Neurologist) and Dr. Hanns Lochmüller (Adult Neurologist)

Other panelists:

  • Dr. Suzanne Salsman (Adult Physiatrist)
  • Dr. Nadim Jiwa (Adult Neurologist)

Saturday, September 11 from 11 a.m. to 2 p.m. EDT: Transition from Pediatric to Adult Care

Moderated by: Dr. Laura McAdam (Pediatrician) and Dr. Colleen O’Connell (Adult Physiatrist)

Agenda:

  • Importance of transition to adult care – Dr. Colleen O’Connell (Adult Physiatrist)
  • CPS guidelines on transition of care – Dr. Laura McAdam (Pediatrician)
  • Transition to adult care services- Dr. Kathryn Selby (Pediatric Neurologist) and Dr. Hana Alazem (Pediatric/Adult Physiatrist)
  • Interactive breakout session 1: How to address current gaps in transition of services
  • Transition to adulthood – Bhavnita Mistry (Research Manager/Coordinator), Dr. Monique Taillon (Pediatric Physiatrist), Dr. Laura McAdam (Pediatrician)
  • Interactive breakout session 2: How to address current gaps in transition to adulthood.
  • Transition resources – Dr. Laura McAdam (Pediatrician)

Other panelists:

  • Dr. Sandrine Boueilh (Pediatric Physiatrist)
  • Dr. Lindsay Hubenig (Pediatric/Adult Physiatrist)
  • Debra Chiabai (Parent)
  • Nancy Klinkhamer (Parent)
  • Mike Klinkhamer (Adult with Becker muscular dystrophy)

Thank you to everyone from our community who completed the pre-event Canadian Duchenne standards of care survey. The results from the survey will be used as a springboard for discussion during the event and prepared for publication thereafter. We hope to see you at the conference!

 

The conference is an Accredited Group Learning Activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by The University of Ottawa’s Office of Continuing Professional Development.

DDCC 2021 - E-Blast Banner FINAL UPDATED

Read next...

Hanns_KarpatiAward

Dr. Hanns Lochmüller Recipient of the Dr. George Karpati Award for Researcher of the Year

The NMD4C are excited to share that the network’s lead investigator Dr. Hanns Lochmüller is the recipient of Muscular Dystrophy Canada’s Dr. George Karpati Award for Researcher of the Year! This prestigious award is presented annually to an exemplary neuromuscular clinician or researcher who has made a significant contribution to neuromuscular research, or the advancement of care of people with neuromuscular disorders. 

Conference_Social_TW_V213

Final Session of the Defeat Duchenne Canadian Conference Wrap-Up and Thank You

Thank you to everyone able to join us for the 2021 Defeat Duchenne Conference Series addressing Duchenne Muscular Dystrophy Standards of Care in Canada. Jesse’s Journey in partnership with NMD4C and MDC are so appreciative of all our speakers and conference chairs who dedicated their time and energy in developing the programs. We successfully generated insightful conversations and discussions on how we might address care gaps in Canada. We are now working towards publishing the proceedings from this conference series to help shape the future of care for your patients and our families living with Duchenne in Canada.

share_events

Share Your Events with the NMD4C

The NMD4C strives to provide opportunities for our members for continuing neuromuscular training, development of knowledge and skills, and collaborate with other neuromuscular stakeholders; If you or your organization are hosting a neuromuscular event, conference or webinar, we would like to help you share it with our neuromuscular members!

2021 YiR_NMD4C

2021 NMD4C Year in Review

The NMD4C wrapped up its 2nd Annual Investigator meeting on Monday, November 29th 2021. This virtual conference served as an opportunity for the network’s investigators to come together and discuss the progress made towards the network’s goals over the past 12 months, with the leaders of the seven working groups presenting the results of their work. With the calendar year wrapping up, it is the perfect opportunity to reflect on all the inspiring progress the NMD4C has made over the past year in pursuit of the network’s goals.

DDCC21_speakers_poster

Session Three of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada to Take Place December 3rd and 4th

The NMD4C is proud to partner with Jesse’s Journey and Muscular Dystrophy Canada (MDC) in hosting the first national summit solely focused on DMD for health care providers across Canada, with the theme for this year’s event being ‘Addressing DMD Standards of Care in Canada.’ Don’t forget to register for the third and final session of the CPD-accredited Defeat Duchenne Canadian Conference, which will take place on the 3rd and 4th of December, 2021.

Networking Event Poster

November 29th Networking Event for all NMD4C Members

The NMD4C are excited to extend an invitation to our members to join us at a Networking Event on November 29th at 2:10pm. This event is open to all NMD4C members and is an opportunity to meet and network with fellow colleagues, early-career clinicians and researchers, NMD4C investigators and working group members, and to discuss all things neuromuscular!